Predicted protein targets (top 4)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MAPT | P10636 | 1/20 | 0.31 |
| ▸ | NQO1 | P15559 | 1/20 | 0.30 |
| ▸ | NQO2 | P16083 | 1/20 | 0.30 |
| ▸ | GPR3 | P46089 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL20910622 | 0.96 | MAPT (0.33) | MAPTNQO1NQO2GPR3 | |
| SCHEMBL20910597 | 0.93 | MAPT (0.32) | MAPTNQO1NQO2GPR3 | |
| SCHEMBL20910621 | 0.91 | MAPT (0.33) | MAPTNQO1NQO2GPR3 | |
| SCHEMBL20910623 | 0.88 | — | — | |
| SCHEMBL20910599 | 0.87 | GPR3 (0.39) | MAPTGPR3 | |
| SCHEMBL20910624 | 0.85 | — | — | |
| SCHEMBL20910598 | 0.83 | GPR3 (0.40) | MAPTGPR3 | |
| SCHEMBL25165738 | 0.81 | NQO1 (0.35) | NQO1NQO2GPR3 | |
| SCHEMBL20910601 | 0.80 | — | — | |
| SCHEMBL25165496 | 0.77 | NQO1 (0.34) | NQO1NQO2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-11242357-B2 | Fused polycyclic heteroaromatic compound and organic thin film and electronic device | SAMSUNG ELECTRONICS CO., LTD. (KR) | 2022-02-08 | — | — | US | disclosed |
| US-20190112319-A1 | FUSED POLYCYCLIC HETEROAROMATIC COMPOUND AND ORGANIC THIN FILM AND ELECTRONIC DEVICE | SAMSUNG ELECTRONICS CO., LTD. (KR) | 2019-04-18 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-11242357-B2 | Fused polycyclic heteroaromatic compound and organic thin film and electronic device | TET1, SLC43A1, OCIAD1 | MAPT 1235/4885NQO1 3229/4885NQO2 4095/4885 |
| US-20190112319-A1 | FUSED POLYCYCLIC HETEROAROMATIC COMPOUND AND ORGANIC THIN FILM AND ELECTRONIC DEVICE | TET1, SLC43A1, OCIAD1 | MAPT 1235/4885NQO1 3229/4885NQO2 4095/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.